Concord Biotech Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	543960	NSE Symbol:	CONCORDBIO	P/E :	48.06
ISIN Demat:	INE338H01029	Div & Yield %:	0.58	EPS :	27.18
Book Value:	193.06	Market Cap (Rs. Cr.):	13,666.01	Face Value :	1

Date	Headline
22-Oct-26	Concord Biotech to review Q2 financial results at board meeting on October 27, 2026
07-Oct-26	Concord Biotech confirmed securities handling compliance with a certificate filed with Indian exchan
28-Sep-26	Concord Biotech halts share trading October 1st pending financial results declaration
19-Sep-26	Concord Biotech to consider bonus equity shares at board meeting on September 23, 2026
29-Jul-26	Concord Biotech to discuss results
08-Jul-26	Concord Biotech schedules AGM
25-Jun-26	Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
12-Jun-26	Concord Biotech's Limbasi unit clears Brazilian health regulatory inspection
10-Jun-26	Concord Biotech receives USFDA approval for Tofacitinib Tablets
02-Jun-26	Concord Biotech receives USFDA approval for Mycophenolate Mofetil for Oral Suspension USP

Company Snapshot